BerandaORX • STO
add
Orexo AB
Tutup sebelumnya
kr 40,80
Rentang hari
kr 37,40 - kr 41,30
Rentang tahun
kr 9,18 - kr 43,40
Kapitalisasi pasar
1,32 M SEK
Volume Rata-Rata
97,68 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 118,20 jt | -23,25% |
Biaya operasional | 128,10 jt | -18,09% |
Laba bersih | -39,80 jt | -10,86% |
Margin laba bersih | -33,67 | -44,44% |
Penghasilan per saham | -1,15 | -10,58% |
EBITDA | -6,90 jt | -428,57% |
Tarif pajak efektif | -17,40% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 121,30 jt | -13,17% |
Total aset | 533,40 jt | -31,02% |
Total liabilitas | 730,40 jt | -2,50% |
Total ekuitas | -197,00 jt | — |
Saham yang beredar | 34,71 jt | — |
Harga terhadap nilai buku | -7,18 | — |
Tingkat pengembalian aset | -8,61% | — |
Tingkat pengembalian modal | -14,73% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -39,80 jt | -10,86% |
Kas dari operasi | -700,00 rb | 89,23% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 4,50 jt | 109,38% |
Perubahan kas bersih | 2,20 jt | 103,77% |
Arus kas bebas | 36,26 jt | 894,79% |
Tentang
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Didirikan
1995
Situs
Karyawan
110
